Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 854607 | ISIN: JP3814000000 | Ticker-Symbol: FJI
Tradegate
30.04.24
16:57 Uhr
20,080 Euro
+0,070
+0,35 %
Branche
Konsumgüter
Aktienmarkt
NIKKEI-225
1-Jahres-Chart
FUJIFILM HOLDINGS CORPORATION Chart 1 Jahr
5-Tage-Chart
FUJIFILM HOLDINGS CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
19,85020,17030.04.
19,88520,07030.04.
GlobeNewswire (Europe)
997 Leser
Artikel bewerten:
(2)

FUJIFILM Europe GmbH: Fujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel

RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) procedures. This innovative simulator, available in two versions - EndoGel for ESD and EndoGel for ESD/POEM - represents a significant advance in endoscopic training. This simulator aims to improve the skills of endoscopy professionals across Europe and ultimately improve patient outcomes.

EndoGel simulates the texture of human tissue involved in ESD and POEM procedures, providing clinicians with a life-like simulation experience. With this unique and innovative training model, endoscopy professionals can benefit from the ability to

- practice marking and injecting,
- performing circumferential incisions,
- performing submucosal dissection, myotomy and clipping.

EndoGel is compatible with a wide range of medical devices used in ESD and POEM procedures, including high frequency devices. It is tailored to work seamlessly with TracMotion, our unique ESD traction device, ensuring a comprehensive training experience. It allows for 6-9 ESD procedures, depending on lesion size and space management. The extended usability ensures cost effectiveness for endoscopy professionals and institutions alike.

Our commitment to enhancing the skills and expertise of endoscopy professionals is in line with our mission to continuously improve patient outcomes.

EndoGel, along with other endoscopy training simulators, will be on display at the ESGE Days in Berlin, Germany, from 25-27 April 2024. Attendees will have the opportunity to explore these innovative simulators and experience their advanced features first-hand.

Fig. 1: Assembled EndoGel simulator

EndoGel

Fig. 2: Endoscopic images

EndoGel ESD training simulator

About Fujifilm Healthcare Europe

After the acquisition of Hitachi's diagnostic imaging business in 2021, the European headquarters of FUJIFILM's Medical Systems Business Unit and FUJIFILM Healthcare Europe (formerly Hitachi Medical Systems Europe) were merged in 2023 to maximise the value of the combined product portfolio. Alongside the formation of the new strategic regional headquarter, various local Fujifilm subsidiaries followed the way of forming dedicated Healthcare entities with the aim of bringing together knowledge, passion and inspiration to create increased value for customers. More than 1500 employees strive to support Healthcare Professionals in improving patients' quality of life by developing the most comprehensive and innovative med-tech solutions portfolio derived from Fujifilm's core competence in medical imaging. For more information, please visit: fujifilm.com.

Contact information

Bachmeier Stefan
Marketing Manager Europe Endoscopy Systems
FUJIFILM Healthcare Europe GmbH
Mail: stefan.bachmeier@fujifilm.com

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/d2ca769c-8fb3-4d70-875a-f68b13c0e45d
https://www.globenewswire.com/NewsRoom/AttachmentNg/434d45f1-0133-4a3f-8b3b-5e16a8b54b96


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.